---
import BaseLayout from '../layouts/BaseLayout.astro';
import ProteinViewer from '../components/ProteinViewer.astro'; 
---

<BaseLayout 
  title="Research"
  description="Projects combining protein biochemistry, assay development, and computational analysis.">
  
  <main>
    <div class="page-header">
      <h1>Research</h1>
      <p class="subtitle">Structural biology and molecular mechanisms.</p>
    </div>

    <section class="figure-container">
      <div class="figure-frame">
        <ProteinViewer />
      </div>
      <figcaption class="figure-caption mono-meta">
        <strong class="caption-label">Figure 1. Structural Architecture of Hsp70.</strong> 
        Interactive 3D rendering of the <em>E. coli</em> DnaK chaperone (PDB: 5NRO). 
        Highlighting the nucleotide-binding domain (NBD) and substrate-binding domain (SBD) 
        architecture required for allosteric regulation.
      </figcaption>
    </section>

    <section class="ledger-wrapper">
      
      <article class="ledger-entry">
        <div class="entry-sidebar">
          <time class="mono-meta">2025</time>
          <span class="status-tag">Structure</span>
        </div>
        <div class="entry-content">
          <h2 class="entry-title">Peptideâ€“Protein Interaction Optimization</h2>
          <p class="entry-body">
            Integrated <strong>AlphaFold 3</strong> structural predictions with fluorescence polarization (FP) 
            assays to drive affinity maturation of protein-binding peptides. Iterative design cycles 
            yielded a 6-fold potency increase (<em>K</em><sub>d</sub>: 30 nM &rarr; 5 nM).
          </p>
          <div class="tag-cloud">
            <span class="tag">AlphaFold 3</span>
            <span class="tag">PyMOL</span>
            <span class="tag">Fluorescence Polarization</span>
          </div>
        </div>
      </article>

      <article class="ledger-entry">
        <div class="entry-sidebar">
          <time class="mono-meta">Submitted</time>
          <span class="status-tag">Manuscript</span>
        </div>
        <div class="entry-content">
          <h2 class="entry-title">High-Throughput Assay for Multi-Protein Systems</h2>
          <p class="entry-body">
            Engineered a 384-well high-throughput screening campaign for the HscA/HscB/IscU chaperone complex. 
            Executed a <strong>1,857-compound pilot screen</strong> on BioTek automation, 
            achieving a Z-factor > 0.6 and establishing protocols for hit validation.
          </p>
          <div class="tag-cloud">
            <span class="tag">Assay Dev</span>
            <span class="tag">Automation</span>
            <span class="tag">Python QC</span>
          </div>
        </div>
      </article>

      <article class="ledger-entry">
        <div class="entry-sidebar">
          <time class="mono-meta">2025</time>
          <span class="status-tag">Cell Chem Bio</span>
        </div>
        <div class="entry-content">
          <h2 class="entry-title">Validating De Novo Designed Proteins</h2>
          <p class="entry-body">
            Validated computational designs through rigorous biophysical characterization. 
            Correlated <em>in silico</em> Rosetta energy scores with experimental binding thermodynamics (MST) 
            and thermal stability (CD) data to verify folding accuracy.
          </p>
          <div class="tag-cloud">
            <span class="tag">Biophysics</span>
            <span class="tag">Design Validation</span>
            <span class="tag">Rosetta</span>
          </div>
        </div>
      </article>

      <article class="ledger-entry">
        <div class="entry-sidebar">
          <time class="mono-meta">2021</time>
          <span class="status-tag">Synthesis</span>
        </div>
        <div class="entry-content">
          <h2 class="entry-title">Small Molecule Inhibitor Synthesis</h2>
          <p class="entry-body">
            Synthesized and purified TMEM16A channel inhibitors via multi-step organic synthesis. 
            Characterized products via <sup>1</sup>H/<sup>13</sup>C NMR and HPLC (>95% purity), 
            supporting structure-activity relationship (SAR) studies.
          </p>
          <div class="tag-cloud">
            <span class="tag">Organic Synthesis</span>
            <span class="tag">HPLC/NMR</span>
            <span class="tag">Medicinal Chem</span>
          </div>
        </div>
      </article>

    </section>
  </main>
</BaseLayout>

<style>
  main {
    max-width: 1000px;
    margin: 0 auto;
    padding: 2rem;
  }

  /* === HEADER === */
  .page-header {
    margin-bottom: 4rem;
    padding-bottom: 1rem;
    border-bottom: 1px solid var(--border);
  }

  h1 {
    font-size: 3rem;
    font-weight: 700;
    color: var(--text-main); 
    margin: 0;
    letter-spacing: -0.05rem;
  }

  .subtitle {
    font-size: 1.15rem;
    color: var(--text-muted);
    margin-top: 0.5rem;
    font-weight: 400;
  }

  /* === FIGURE HERO === */
  .figure-container {
    margin-bottom: 5rem;
  }

  .figure-frame {
    border: 1px solid var(--border);
    padding: 0.5rem;
    background: var(--bg-surface);
    border-radius: 4px;
    box-shadow: 0 4px 20px rgba(0,0,0,0.05);
  }

  .figure-caption {
    margin-top: 1rem;
    font-size: 0.9rem;
    color: var(--text-muted);
    padding-left: 1rem;
    border-left: 2px solid var(--border);
    line-height: 1.5;
  }

  .caption-label {
    color: var(--text-main); 
    font-weight: 600;
  }

  /* === LEDGER LIST === */
  .ledger-wrapper {
    display: flex;
    flex-direction: column;
    gap: 4rem;
  }

  .ledger-entry {
    display: grid;
    grid-template-columns: 140px 1fr; 
    gap: 2rem;
    align-items: flex-start;
  }

  /* SIDEBAR: Petrol Blue Accents */
  .entry-sidebar {
    text-align: right;
    display: flex;
    flex-direction: column;
    gap: 0.5rem;
    padding-top: 0.35rem;
    border-right: 2px solid var(--accent-primary);
    padding-right: 1.5rem; 
  }

  .entry-sidebar time {
    font-size: 0.9rem;
    color: var(--text-main); 
    font-weight: 500;
  }

  .status-tag {
    font-size: 0.75rem;
    font-family: var(--font-mono);
    color: var(--accent-primary);
    opacity: 0.9;
  }

  /* CONTENT */
  .entry-title {
    font-size: 1.5rem;
    margin-top: 0;
    margin-bottom: 0.75rem;
    color: var(--text-main);
    letter-spacing: -0.01em;
  }

  .entry-body {
    font-size: 1.05rem;
    color: var(--text-muted);
    line-height: 1.6;
    margin-bottom: 1.5rem;
  }

  .entry-body strong {
    color: var(--text-main);
    font-weight: 600;
  }

  /* TAGS */
  .tag-cloud {
    display: flex;
    flex-wrap: wrap;
    gap: 0.5rem;
  }

  .tag {
    font-size: 0.75rem;
    font-family: var(--font-mono);
    color: var(--accent-primary);
    background: color-mix(in srgb, var(--accent-primary), transparent 92%);
    padding: 0.25rem 0.6rem;
    border-radius: 4px;
    border: 1px solid transparent;
    transition: all 0.2s ease;
  }

  .tag:hover {
    border-color: var(--accent-primary);
    background: transparent;
  }

  /* === MOBILE === */
  @media (max-width: 768px) {
    h1 { font-size: 2.5rem; }

    .ledger-entry {
      grid-template-columns: 1fr;
      gap: 0.5rem;
      padding-bottom: 2rem;
      border-bottom: 1px solid var(--border);
    }
    .ledger-entry:last-child { border-bottom: none; }

    .entry-sidebar {
      flex-direction: row;
      text-align: left;
      align-items: center;
      gap: 0.75rem;
      padding-top: 0;
      border-right: none;
      border-left: 2px solid var(--accent-primary);
      padding-left: 0.75rem;
      margin-bottom: 0.5rem;
    }
  }
</style>